Many research reports that, in several tumour cell types, the forced overexpression of Bcl-2 has been considered resistance to chemotherapeutic agents (Pilco-Ferreto and Calaf 2016; Wang and Teng 2016). The gene discussed is BCL2; the disease is neoplasm.